First Time Loading...
A

Acticor Biotech SA
PAR:ALACT

Watchlist Manager
Acticor Biotech SA
PAR:ALACT
Watchlist
Price: 0.336 EUR 24.44%
Updated: Apr 29, 2024
Section:
 

Wall Street
Price Targets

ALACT Price Targets Summary
Acticor Biotech SA

Wall Street analysts forecast ALACT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ALACT is 11.475 EUR with a low forecast of 11.11 EUR and a high forecast of 12.075 EUR.

ALACT Lowest Forecast
Wall Street Target
11.11 EUR
3 207% Upside
ALACT Average Forecast
Wall Street Target
11.475 EUR
3 315% Upside
ALACT Highest Forecast
Wall Street Target
12.075 EUR
3 494% Upside
Lowest
Price Target
11.11 EUR
3 207% Upside
Average
Price Target
11.475 EUR
3 315% Upside
Highest
Price Target
12.075 EUR
3 494% Upside
Acticor Biotech SA Competitors:
Price Targets
T
6628
Transcenta Holding Limited
372% Upside
ACHV
Achieve Life Sciences Inc
336% Upside
A
AELIS
Aelis Farma SA
67% Upside
S
SABS
SAB Biotherapeutics Inc
332% Upside
T
6628
Transcenta Holding Limited
372% Upside
ACHV
Achieve Life Sciences Inc
336% Upside
A
AELIS
Aelis Farma SA
67% Upside
S
SABS
SAB Biotherapeutics Inc
332% Upside
NGNE
Neurogene Inc
55% Upside
K
2162
KeyMed Biosciences Inc
87% Upside
688363
Bloomage Biotechnology Corp Ltd
60% Upside
CDMO
Avid Bioservices Inc
70% Upside

Revenue
Forecast

Revenue Estimate
Acticor Biotech SA

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Acticor Biotech SA

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Acticor Biotech SA

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

See Also

Summary
ALACT intrinsic value, competitors valuation, and company profile.
DCF Valuation
ALACT stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ALACT stock valuation using valuation multiples.
Wall Street Estimates
ALACT price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ALACT stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ALACT's stock price target?
Price Target
11.475 EUR

According to Wall Street analysts, the average 1-year price target for ALACT is 11.475 EUR with a low forecast of 11.11 EUR and a high forecast of 12.075 EUR.

ALPHA SPREAD
Join more than 132,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.